Nebulization Therapy for Asthma: A Practical Guide for the Busy Pediatrician

Abstract

Get full access to this article

View all access options for this article.

References

O'Callaghan C. , Barry PW How to choose delivery devices for asthma . Arch Dis Child. 2000;82:185-191.

Berger WE Paediatric pulmonary drug delivery: considerations in asthma treatment . Expert Opin Drug Deliv. 2005;2:965-980.

De Benedictis FM , Selvaggio D. Use of inhaler devices in pediatric asthma . Paediatr Drugs. 2003;5:629-638.

American Academy of Allergy Asthma and Immunology and American Academy of Pediatrics. Pediatric asthma promoting best practice: guide for managing asthma in children. 2004. American Academy of Allergy Asthma and Immunology. http://www.aaaai.org/members/resources/initiatives/pediatricasthma.stm . Accessed January 17, 2007.

Dolovich MB , Ahrens RC , Hess DR , et al; for American College of Chest Physicians and the American College of Asthma, Allergy, and Immunology. Device selection and outcomes of aerosol therapy: evidence-based guidelines . Chest. 2005;127:335-371.

Welch MJ , Smaldone GC Effective use of nebulizer systems in pediatric asthma therapy. Adv Phys Assist. 2002; 10:52.

Larsen JS , Hahn M. , Ekholm B. , Wick KA Evaluation of conventional press-and-breathe metered-dose inhaler technique in 501 patients. J Asthma. 1994;31:193-199.

Kamps AW , van Ewijk B. , Roorda RJ , Brand PL Poor inhalation technique, even after inhalation instructions, in children with asthma. Pediatr Pulmonol. 2000 ;29: 39-42.

Crompton GK Problems patients have using pressurized aerosol inhalers. Eur J Respir Dis Suppl. 1982;119: 101-104.

10.

De Blaquiere P. , Christensen DB , Carter WB , Martin TR Use and misuse of metered-dose inhalers by patients with chronic lung disease. A controlled, randomized trial of two instruction methods. Am Rev Respir Dis. 1989 ; 140:910-916.

11.

Szefler SJ Clinical need for a nebulized corticosteroid. J Allergy Clin Immunol. 1999;104:162S-168S.

12.

Pedersen S. Inhalers and nebulizers: which to choose and why. Respir Med. 1996;90:69-77.

13.

American Academy of Allergy Asthma and Immunology. Allergy and asthma medication guide: inhaled corticosteroids . http://www.aaaai.org/patients/resources/medication_guide/inhaledcorticosteroidstable.stm. Accessed December 4, 2006.

14.

National Asthma Education and Prevention Program. Expert panel report: guidelines for the diagnosis and management of asthma-update on selected topics 2002. J Allergy Clin Immunol. 2002;110 (suppl):141S-219S.

15.

Alupent® (metaproterenol sulfate) [prescribing information] . Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals Inc; 2005.

16.

Robertson CF , Norden MA , Fitzgerald DA , et al. Treatment of acute asthma: salbutamol via jet nebuliser vs spacer and metered dose inhaler . J Paediatr Child Health. 1998;34:142-146.

17.

Castro-Rodriguez JA , Rodrigo GJ β-agonists through metered-dose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: a systematic review with meta-analysis . J Pediatr. 2004;145:172-177.

18.

Batra V. , Sethi GR , Sachdev HPS. Comparative efficacy of jet nebulizer and metered dose inhaler with spacer device in the treatment of acute asthma. Indian Pediatr . 1997;34:497-503.

19.

Chou KJ , Cunningham SJ , Crain EF Metered-dose inhalers with spacers vs nebulizers for pediatric asthma . Arch Pediatr Adolesc Med. 1995;149:201-205.

20.

Closa RM , Ceballos JM , Gómez-Papí A. , Galiana AS , Gutiérrez C. , Martí-Henneber C. Efficacy of bronchodilators administered by nebulizers versus spacer devices in infants with acute wheezing. Pediatr Pulmonol. 1998; 26:344-348.

21.

Cates CJ , Crilly JA , Rowe BH Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev. 2006;(2):CD000052. doi: 10.1002/14651858.CD000052.pub2.

22.

Delgado A. , Chou KJ , Silver EJ , Crain EF Nebulizers vs metered-dose inhalers with spacers for bronchodilator therapy to treat wheezing in children aged 2 to 24 months in a pediatric emergency department. Arch Pediatr Adolesc Med. 2003 ;157:76-80.

23.

Dewar AL , Stewart A. , Cogswell JJ , Connett GJ A randomised controlled trial to assess the relative benefits of large volume spacers and nebulisers to treat acute asthma in hospital. Arch Dis Child. 1999;80:421-423.

24.

Korem E. , Levison H. , Schuh S. , et al. Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma. J Pediatr. 1993;123:313-317.

25.

Leversha AM , Campanella SG , Aickin RP , Asher MI Costs and effectiveness of spacer versus nebulizer in young children with moderate and severe acute asthma. J Pediatr. 2000;136:497-502.

26.

Mandelberg A. , Tsehori S. , Houri S. , Gilad E. , Morag B. , Priel IE Is nebulized aerosol treatment necessary in the pediatric emergency department? Comparison with a metal spacer device for metered-dose inhaler. Chest. 2000;117:1309-1313.

27.

Ploin D. , Chapuis FR , Stamm D. , et al. High-dose albuterol by metered-dose inhaler plus a spacer device versus nebulization in preschool children with recurrent wheezing: a double-blind, randomized equivalence trial. Pediatrics. 2000;106:311-317.

28.

Rubilar L. , Castro-Rodriguez JA , Girardi G. Randomized trial of salbutamol via metered-dose inhaler with spacer versus nebulizer for acute wheezing in children less than 2 years of age. Pediatr Pulmonol. 2000;29:264-269.

29.

Schuh S. , Johnson DW , Stephens D. , Callahan S. , Winders P. , Canny GJ Comparison of albuterol delivered by a metered dose inhaler with spacer versus a nebulizer in children with mild acute asthma. J Pediatr . 1999;135:22-27.

30.

Williams JR , Bothner JP , Swanton RD Delivery of albuterol in a pediatric emergency department. Pediatr Emerg Care. 1996;12:263-267.

31.

Lin YZ , Hsieh KH Metered dose inhaler and nebuliser in acute asthma. Arch Dis Child. 1995;72:214-218.

32.

O'Reilly JF , Weir DC , Banham S. , Basran GS , Boyd G. , Patel KR

Is high-dose fluticasone propionate via a metered-dose inhaler and Volumatic™ as efficacious as nebulized budesonide in adult asthmatics?

Respir Med. 1998;92:111-117.

33.

Bisgaard H. , Nikander K. , Munch E. Comparative study of budesonide as a nebulized suspension vs pressurized metered-dose inhaler in adult asthmatics. Respir Med. 1998;92:44-49.

34.

Guilbert TW , Morgan WJ , Zeiger RS , et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med. 2006;354:1985-1997.

35.

Teper AM , Kofman CD , Szulman GA , Vidaurreta SM , Maffey AF Fluticasone improves pulmonary function in children under 2 years old with risk factors for asthma. Am J Respir Crit Care Med . 2005;171:587-590.

36.

Wasserman RL , Baker JW , Kim KT , et al. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study. Ann Allergy Asthma Immunol. 2006;96:808-818.

37.

Bisgaard H. , Allen D. , Milanowski J. , Kalev I. , Willits L. , Davies P. Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing. Pediatrics . 2004;113:87-94.

38.

Bisgaard H. , Gillies J. , Groenewald M. , Maden C. ; for an International Study Group. The effect of inhaled fluticasone propionate in the treatment of young asthmatic children. A dose comparison study. Am J Respir Crit Care Med. 1999;160:126-131.

39.

Lødrup Carlsen KC , Stick S. , Kamin W. , Cirule I. , Hughes S. , Wixon C. The efficacy and safety of fluticasone propionate in very young children with persistent asthma symptoms. Respir Med. 2005;99:1393-1402.

40.

Berger WE , Shapiro GG The use of inhaled corticosteroids for persistent asthma in infants and young children. Ann Allergy Asthma Immunol. 2004 ;92:387-400.

41.

Agertoft L. , Andersen A. , Weibull E. , Pedersen S. Systemic availability and pharmacokinetics of nebulised budesonide in preschool children. Arch Dis Child . 1999;80: 241-247.

42.

Lødrup Carlsen KC , Nikander K. , Carlsen KH How much nebulised sudesonide reaches infants and toddlers? Arch Dis Child. 1992;67:1077-1079.

43.

Baker JW , Mellon M. , Wald J. , Welch M. , Cruz-Rivera M. , Walton-Bowen K. A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants. Pediatrics. 1999 ;103:414-421.

44.

Berger WE , Qaqundah PY , Blake K. , et al. Safety of budesonide inhalation suspension in infants aged six to twelve months with mild to moderate persistent asthma or recurrent wheeze . J Pediatr. 2005;146:91-95.

45.

De Blic J. , Delacourt C. , Le Bourgeois M. , et al. Efficacy of nebulized budesonide in treatment of severe infantile asthma: a double-blind study. J Allergy Clin Immunol. 1996;98:14-20.

46.

Irani AM , Cruz-Rivera M. , Fitzpatrick S. , Hoag J. , Smith JA Effects of budesonide inhalation suspension on hypothalamic-pituitary-adrenal-axis function in infants and young children with persistent asthma. Ann Allergy Asthma Immunol. 2002;88:306-312.

47.

Kemp JP , Skoner DP , Szefler SJ , Walton-Bowen K. , Cruz-Rivera M. , Smith JA Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children. Ann Allergy Asthma Immunol . 1999;83:231-239.

48.

Leflein JG , Gawchik SM , Galant SP , et al. Safety of budesonide inhalation suspension (Pulmicort Respules) after up to 52 weeks of treatment in infants and young children with persistent asthma. Allergy Asthma Proc. 2001;22:359-366.

49.

Leflein JG , Szefler SJ , Murphy KR , et al. Nebulized budesonide inhalation suspension compared with cromolyn sodium nebulizer solution for asthma in young children: results of a randomized outcomes trial. Pediatrics. 2002;109:866-872.

50.

Szefler SJ , Lyzell E. , Fitzpatrick S. , Cruz-Rivera M. Safety profile of budesonide inhalation suspension in the pediatric population: worldwide experience. Ann Allergy Asthma Immunol . 2004;93:83-90.

51.

Nikander K. Some technical, physicochemical and physiological aspects of nebulization of drugs. Eur Respir Rev. 1997;7:168-172.

52.

Kendrick AH , Smith EC , Wilson RSE. Selecting and using nebuliser equipment . Thorax. 1997;52(suppl 2): 92S-101S.

53.

Muers MF The rational use of nebulisers in clinical practice. Eur Respir Rev. 1997;7:189-197.

54.

O'Callaghan C. , Barry PW The science of nebulised drug delivery . Thorax. 1997;52(suppl 2):31S-44S.

55.

Nikander K. Drug delivery systems. J Aerosol Med. 1994;7:19S-24S.

56.

Leung K. , Louca E. , Coates AL Comparison of breath-enhanced to breath-actuated nebulizers for rate, consistency, and efficiency. Chest. 2004;126:1619-1627.

57.

Denyer J. , Nikander K. , Smith NJ Adaptive aerosol delivery (AAD®) technology. Expert Opin Drug Deliv. 2004;1:165-176.

58.

O'Callaghan C. , White J. , Jackson J. , Barry PW , Kantar A. Delivery of nebulized budesonide is affected by nebulizer type and breathing pattern. J Pharm Pharmacol . 2005;57:787-790.

59.

Barry PW , O'Callaghan C. An in vitro analysis of the output of budesonide from different nebulizers . J Allergy Clin Immunol. 1999;104:1168-1173.

60.

Reisner C. , Katial RK , Bartelson BB , Buchmeir A. , Rosenwasser LJ , Nelson HS Characterization of aerosol output from various nebulizer/compressor combinations . Ann Allergy Asthma Immunol. 2001;86:566-574.

61.

Hess D. , Fisher D. , Williams P. , Pooler S. , Kacmarek RM Medication nebulizer performance. Effects of diluent volume, nebulizer flow, and nebulizer brand. Chest. 1996;110:498-505.

62.

Barry PW , O'Callaghan C. The output of budesonide from nebulisers. J Allergy Clin Immunol . 1998;102: 321-322.

63.

Smaldone GC , Cruz-Rivera M. , Nikander K. In vitro determination of inhaled mass and particle distribution for budesonide nebulizing suspension . J Aerosol Med. 1998;11:113-125.

64.

Pulmicort Respules® (budesonide inhalation suspension) [prescribing information] . Wilmington, DE: AstraZeneca LP ; 2007.

65.

AccuNeb® (albuterol sulfate) inhalation solution [prescribing information] . Napa, CA: DEY; 2005.

66.

Medical News Today. PARI named leading nebulizer company in Cambridge consulting survey. http://www.medicalnewstoday.com/printerfriendlynews.php?newsid=45575. Accessed January 17, 2007.

67.

Tobi® (tobramycin inhalation solution) [prescribing information]. Emeryville, CA: Chiron Corporation; 2004.

68.

Brovana™ (arformoterol tartrate) inhalation solution [prescribing information] . Marlborough, MA: Sepracor, Inc ; 2006.

69.

Xopenex® (levalbuterol HCL) inhalation solution [prescribing information] . Marlborough, MA: Sepracor, Inc ; 2002.

70.

Pallares DE , Pilarski BR , Rodriguez JL , Leickly FE A comparison of bronchodilator responses to albuterol delivered by ultrasonic versus jet nebulization in moderate to severe asthma. Ann Allergy Asthma Immunol. 1996;77:292-297.

71.

Nakanishi AK , Lamb BM , Foster C. , Rubin BK Ultrasonic nebulization of albuterol is no more effective than jet nebulization for the treatment of acute asthma in children. Chest. 1997;111:1505-1508.

72.

Nikander K. , Turpeinen M. , Wollmer P. The conventional ultrasonic nebulizer proved inefficient in nebulizing a suspension. J Aerosol Med. 1999;12:47-53.

73.

PARI Aerosol Research Institute. http://www.paripharma.com/technologies1.htm. Accessed February 8, 2007.

74.

Berlinski A. , Waldrep JC Nebulized drug admixtures: effect on aerosol characteristics and albuterol output. J Aerosol Med. 2006;19:484-490.

75.

McKenzie JE , Cruz-Rivera M. Compatibility of budesonide inhalation suspension with four nebulizing solutions. Ann Pharmacother . 2004;38:967-972.

76.

Kamin W. , Schwabe A. , Krämer I. Inhalation solutions- which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers. J Cyst Fibros . 2006;5:205-213.

77.

Gruber C. , Moenkhoff M. , Hamacher J. , Frey U. , Sennhauser FH , Wildhaber JH The influence of a nose-clip on inhalation therapy in asthmatic children . Pediatr Asthma Allergy Immunol. 2003;16:129-135.

78.

Lowenthal D. , Kattan M. Facemasks versus mouthpieces for aerosol treatment of asthmatic children. Pediatr Pulmonol . 1992 ;14:192-196.

79.

Georgitis JW , McWilliams B. , Cruz-Rivera M. , Fitzpatrick S. , Smith JA Effective once-daily administration of budesonide inhalation suspension by nebulizer with facemasks or mouthpieces for persistent asthma in infants and young children. Pediatr Asthma Allergy Immunol. 2001;15:3-13.

80.

Mellon M. , Leflein J. , Walton-Bowen K. , Cruz-Rivera M. , Fitzpatrick S. , Smith JA Comparable efficacy of administration with face mask or mouthpiece of nebulized budesonide inhalation suspension for infants and young children with persistent asthma. Am J Respir Crit Care Med. 2000;162:593-598.

81.

Rubin BK Nebulizer therapy for children: the device-patient interface. Respir Care. 2002;47:1314-1319.

82.

Everard ML , Clark AR , Milner AD Drug delivery from jet nebulisers. Arch Dis Child . 1992;67:586-591.

83.

Restrepo RD , Dickson SK , Rau JL , Gardenshire DS An investigation of nebulized bronchodilator delivery using a pediatric lung model of spontaneous breathing. Respir Care. 2006;51:56-61.

84.

Iles R. , Lister P. , Edmunds AT Crying significantly reduces absorption of aerosolized drug in infants . Arch Dis Child. 1999;81:163-165.

85.

Murakami G. , Igarashi T. , Adachi Y. , et al. Measurement of bronchial hyperreactivity in infants and preschool children using a new method. Ann Allergy. 1990;64: 383-387.

86.

Standaert TA , Morlin GL , Williams-Warren J. , et al. Effects of repetitive use and cleaning techniques of disposable jet nebulizers on aerosol generation . Chest. 1998;114:577-586.

87.

Merkus PJ , van Essen-Zandvliet EE , Parlevliet E. , et al. Changes of nebulizer output over the years. Eur Respir J. 1992;5:488-491.

88.

Tablan OC , Anderson LJ , Arden NH , Breiman RF , Butler JC , McNeil MM ; for Hospital Infection Control Practices Advisory Committee and the Centers for Disease Control and Prevention. Guideline for prevention of nosocomial pneumonia. Am J Infect Control. 1994;22:247-292.

89.

Craven DE , Lichtenberg DA , Goularte TA , Make BJ , McCabe WR Contaminated medication nebulizers in mechanical ventilator circuits. Source of bacterial aerosols. Am J Med. 1984 ;77:834-838.

90.

Hamill RJ , Houston ED , Georghiou PR , et al. An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy . Ann Intern Med. 1995;122:762-766.

91.

Oie S. , Makieda D. , Ishida S. , Okano Y. , Kamiya A. Microbial contamination of nebulization solution and its measures . Biol Pharm Bull. 2006;29:503-507.

92.

Everard ML Inhaler devices in infants and children: challenges and solutions . J Aerosol Med. 2004;17: 186-195.

93.

Schöni MH , Horak E. , Nikolaizik WH Compliance with therapy in children with respiratory diseases. Eur J Pediatr. 1995;154(suppl 3):77S-81S.

94.

Iqbal S. , Ritson S. , Prince I. , Denyer J. , Everard ML Drug delivery and adherence in young children. Pediatr Pulmonol . 2004;37:311-317.

95.

Cochrane MG , Bala MV , Downs KE , Mauskopf J. , Ben-Joseph RH Inhaled corticosteroids for asthma therapy. Patient compliance, devices, and inhalation technique . Chest . 2000;117:542-550.

96.

Rau JL Determinants of patient adherence to an aerosol regimen. Respir Care. 2005;50:1346-1356.

97.

Graves MM , Adams CD , Portnoy JM Adherence in young children with asthma. Curr Opin Allergy Clin Immunol. 2006;6:124-127.

98.

Prabhakaran L. , Lim G. , Abisheganaden J. , Chee CB , Choo YM Impact of an asthma education programme on patients' knowledge, inhaler technique and compliance to treatment. Singapore Med J. 2006;47:225-231.

99.

Cole CH Special problems in aerosol delivery: neonatal and pediatric considerations . Respir Care. 2000;45:646-651.

100.

Gillies J. Overview of delivery system issues in pediatric asthma. Pediatr Pulmonol Suppl. 1997;15:55-58.

101.

Brand PL Key issues in inhalation therapy in children. Curr Med Res Opin. 2005;21(suppl 4):27S-32S.